EXENCIAL WEALTH ADVISORS, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXENCIAL WEALTH ADVISORS, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$291,340
+19.4%
9,0450.0%0.02%0.0%
Q3 2022$244,000
-78.4%
9,045
-77.7%
0.02%
-69.4%
Q3 2021$1,130,000
-6.0%
40,5550.0%0.05%
-24.6%
Q2 2021$1,202,000
+6.0%
40,5550.0%0.06%
-3.0%
Q1 2021$1,134,000
-3.9%
40,555
-2.6%
0.07%
-17.3%
Q4 2020$1,180,000
+73.8%
41,630
+54.2%
0.08%
+125.0%
Q3 2020$679,000
+3.8%
26,994
+0.7%
0.04%
-36.8%
Q2 2020$654,000
+67.7%
26,794
+1.8%
0.06%
-18.6%
Q1 2020$390,000
-8.5%
26,332
+0.4%
0.07%
-5.4%
Q4 2019$426,000
+26.8%
26,232
+1.4%
0.07%
+2.8%
Q3 2019$336,000
+150.7%
25,882
+150.1%
0.07%
+132.3%
Q2 2019$134,000
-17.8%
10,3500.0%0.03%
-20.5%
Q1 2019$163,000
-37.1%
10,350
-19.5%
0.04%
-44.3%
Q4 2018$259,000
-18.8%
12,8500.0%0.07%
-5.4%
Q3 2018$319,000
-26.2%
12,850
-18.4%
0.07%
-38.3%
Q2 2018$432,000
-4.8%
15,744
+6.8%
0.12%
-11.1%
Q1 2018$454,000
-7.0%
14,744
+8.1%
0.14%
-8.2%
Q4 2017$488,00013,6440.15%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders